tetano
Editor, Senior Moderator
Geriatr Gerontol Int
. 2020 Dec 19.
doi: 10.1111/ggi.14107. Online ahead of print.
Prevalence of dementia and its impact on mortality in patients with coronavirus disease 2019: A systematic review and meta-analysis
Julius July[SUP] 1 [/SUP], Raymond Pranata[SUP] 2 [/SUP]
Affiliations
Abstract
Aim: In this systematic review and meta-analysis, we aimed to evaluate the prevalence of dementia in patients with COVID-19 and its association with mortality. We also aimed to discover whether age, sex and other comorbidities might affect the association between dementia and mortality.
Methods: We carried out a systematic literature search using PubMed, SCOPUS, EuropePMC and the Cochrane Central Database. The outcome of interest was mortality, defined as clinically validated mortality/death/non-survivor in the studies. The pooled effect estimates were presented as odds ratio and adjusted odds ratio.
Results: A total of 56 577 patients from 10 studies were included. The prevalence of dementia in this pooled analysis was 10% (7-13%). Dementia was associated with increased mortality in both pooled unadjusted (odds ratio 2.80, 95% CI 1.85-4.24, P < 0.001; I[SUP]2[/SUP] = 93.7%) and adjusted effect estimates (adjusted odds ratio 1.80, 95% CI 1.45-2.24, P < 0.001; I[SUP]2[/SUP] = 72.9%). The association between dementia and mortality was influenced by age (coefficient -0.047, P < 0.001) and hypertension (coefficient -0.009, P = 0.020).
Conclusions: This study showed that dementia was associated with increased mortality in COVID-19 patients. The association was affected by age and comorbidities. Geriatr Gerontol Int 2020; ••: ••-••.
Keywords: Alzheimer; coronavirus; dementia; prognosis; risk stratification.
. 2020 Dec 19.
doi: 10.1111/ggi.14107. Online ahead of print.
Prevalence of dementia and its impact on mortality in patients with coronavirus disease 2019: A systematic review and meta-analysis
Julius July[SUP] 1 [/SUP], Raymond Pranata[SUP] 2 [/SUP]
Affiliations
- PMID: 33340212
- DOI: 10.1111/ggi.14107
Abstract
Aim: In this systematic review and meta-analysis, we aimed to evaluate the prevalence of dementia in patients with COVID-19 and its association with mortality. We also aimed to discover whether age, sex and other comorbidities might affect the association between dementia and mortality.
Methods: We carried out a systematic literature search using PubMed, SCOPUS, EuropePMC and the Cochrane Central Database. The outcome of interest was mortality, defined as clinically validated mortality/death/non-survivor in the studies. The pooled effect estimates were presented as odds ratio and adjusted odds ratio.
Results: A total of 56 577 patients from 10 studies were included. The prevalence of dementia in this pooled analysis was 10% (7-13%). Dementia was associated with increased mortality in both pooled unadjusted (odds ratio 2.80, 95% CI 1.85-4.24, P < 0.001; I[SUP]2[/SUP] = 93.7%) and adjusted effect estimates (adjusted odds ratio 1.80, 95% CI 1.45-2.24, P < 0.001; I[SUP]2[/SUP] = 72.9%). The association between dementia and mortality was influenced by age (coefficient -0.047, P < 0.001) and hypertension (coefficient -0.009, P = 0.020).
Conclusions: This study showed that dementia was associated with increased mortality in COVID-19 patients. The association was affected by age and comorbidities. Geriatr Gerontol Int 2020; ••: ••-••.
Keywords: Alzheimer; coronavirus; dementia; prognosis; risk stratification.